$141 Million is the total value of Kalos Management, Inc.'s 130 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC COM | $364,000 | +19.0% | 10,600 | 0.0% | 0.26% | +4.5% | |
| MORE | MONOGRAM RESIDENTIAL TR INC COM | $165,000 | -8.3% | 16,593 | 0.0% | 0.12% | -19.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 30 | Q2 2023 | 2.9% |
| APPLE INC COM | 29 | Q2 2023 | 2.7% |
| ISHARES TRUST | 29 | Q2 2023 | 1.3% |
| ISHARES TR | 28 | Q2 2023 | 5.9% |
| VANGUARD S&P 500 ETF IV | 28 | Q2 2023 | 4.2% |
| ISHARES US HEALTHCARE ETF IV | 28 | Q2 2023 | 4.7% |
| VANGUARD TAX-MANAGED FDS | 28 | Q1 2023 | 1.3% |
| SPDR S&P EMERGING MRKT SML CP ETF | 28 | Q2 2023 | 1.2% |
| ISHARES US TECHNOLOGY ETF | 28 | Q2 2023 | 1.8% |
| SPDR S&P 500 VALUE ETF IV | 28 | Q2 2023 | 0.7% |
View Kalos Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-27 |
| 13F-HR | 2022-11-21 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-06-21 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-11 |
View Kalos Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.